J&J | JNJ - Ordinary Share Capital


J&J reported $2.41B in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Abbott USD 1.74B 2.94M Mar/2026
Amgen USD 541M 1000K Jun/2026
AstraZeneca USD 1.55B 44K Jun/2026
Baxter International USD 517M 549K Jun/2026
Bayer EUR 982.42M 0 Mar/2026
Becton, Dickinson and Co. USD 275.54M 9.37M Mar/2026
Biogen USD 146.7M 200K Sep/2025
Boston Scientific USD 1.48B 2.66M Dec/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
CONMED USD 29.99M 157K Jun/2026
Cooper Companies USD 195.11M 14K Mar/2026
Dexcom USD 377.4M 8.5M Jun/2026
Edwards Lifesciences USD 577M 3.7M Mar/2026
Eli Lilly USD 943.5M 3.33M Mar/2026
Gilead Sciences USD 1.24B 1000K Jun/2026
GlaxoSmithKline GBP 4.08B 20.6M Jun/2026
Globus Medical USD 135.67M 611K Mar/2026
Insulet USD 69.35M 87K Jun/2026
Integra LifeSciences USD 77.78M 39K Jun/2026
Intuitive Surgical USD 354.16M 1.01M Jun/2026
J&J USD 2.41B 1.35M Mar/2026
Medtronic USD 1.28B 1.38M Dec/2025
Merck USD 2.47B 4.93M Mar/2026
Merit Medical Systems USD 59.71M 55K Jun/2026
Novartis USD 1.9B 7.38M Jun/2026
Pfizer USD 5.7B 0 Jun/2026
Regeneron Pharmaceuticals USD 105M 300K Mar/2026
Roche Holding CHF 796.77M 1.15M Jun/2026
Sanofi EUR 1.21B 8.25M Mar/2026
Stryker USD 383.4M 416K Jun/2026
Tandem Diabetes Care USD 68.5M 213K Mar/2026
Teva Pharmaceutical Industries USD 1.16B 1000K Jun/2026
Vertex Pharmaceuticals USD 253.3M 900K Jun/2026
Zimmer Biomet Holdings USD 193.4M 2.1M Jun/2026
Zoetis USD 420.35M 4.58M Mar/2026